Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes
| 대상 질환 | Obesity, Type2 Diabetes, Bariatric Surgery Candidate |
|---|---|
| 임상 단계 | 단계 해당 없음 |
| 스폰서 | The Cleveland Clinic |
| 상태 | 완료 |
| 참여자 수 | 91,700 명 |
| 중재(약물) | Bariatric Surgery |
| 시작일 | 2019년 6월 5일 |
| 완료일 | 2019년 7월 12일 |
| 결과 공개일 | 2026년 8월 3일 |
요약
The objective of the analysis was to evaluate the relationship between bariatric surgery and cardiovascular outcomes in obese patients with type 2 diabetes.
All-Cause Mortality and/or Cardiovascular Outcomes
| Bariatric Surgery | 30.8 percentage of participants |
|---|---|
| Non-Surgical Control | 47.7 percentage of participants |
BENITIONS에서 보기 ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
- Diabetes Prevention Program Outcomes Study — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Uric Acid Lowering Trial in Youth Onset T2D — University of Colorado, Denver
- Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1 — State University of New York at Buffalo
- Continuous Glucose Monitoring Following Hospital Discharge — Kathleen Dungan
- Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on I — University of Colorado, Denver
- A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus — Eli Lilly and Company